ATE113636T1 - Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe. - Google Patents

Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.

Info

Publication number
ATE113636T1
ATE113636T1 AT90903989T AT90903989T ATE113636T1 AT E113636 T1 ATE113636 T1 AT E113636T1 AT 90903989 T AT90903989 T AT 90903989T AT 90903989 T AT90903989 T AT 90903989T AT E113636 T1 ATE113636 T1 AT E113636T1
Authority
AT
Austria
Prior art keywords
composition
body tissue
tissue adhesion
preventing body
range
Prior art date
Application number
AT90903989T
Other languages
English (en)
Inventor
Gert Lindblad
Peter Buckley
Original Assignee
Pharmacia Biosystems Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Biosystems Ab filed Critical Pharmacia Biosystems Ab
Application granted granted Critical
Publication of ATE113636T1 publication Critical patent/ATE113636T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesives Or Adhesive Processes (AREA)
AT90903989T 1989-02-21 1990-02-21 Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe. ATE113636T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8900586A SE8900586L (sv) 1989-02-21 1989-02-21 Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader

Publications (1)

Publication Number Publication Date
ATE113636T1 true ATE113636T1 (de) 1994-11-15

Family

ID=20375109

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90903989T ATE113636T1 (de) 1989-02-21 1990-02-21 Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.

Country Status (7)

Country Link
US (2) US5190759A (de)
EP (1) EP0418339B1 (de)
AT (1) ATE113636T1 (de)
DE (1) DE69013833T2 (de)
DK (1) DK0418339T3 (de)
SE (1) SE8900586L (de)
WO (1) WO1990010031A1 (de)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
JP2855307B2 (ja) * 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
US5611354A (en) * 1992-11-12 1997-03-18 Alleyne; Neville Cardiac protection device
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5807833A (en) * 1995-06-07 1998-09-15 University Of Southern California Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device
US5612321A (en) * 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
EP0859597B1 (de) * 1995-09-29 2003-04-09 LAM Pharmaceutical Corporation Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US5716631A (en) * 1995-09-29 1998-02-10 Rdn Therapeutics Inc. Long acting narcotic analgesics and antagonists
US6541460B2 (en) 1996-08-07 2003-04-01 George D. Petito Method for use of hyaluronic acid in wound management
SE9702698D0 (sv) * 1997-07-14 1997-07-14 Stig Bengmark Compositions for lubricating and separating tissues and biological membranes
GB9810127D0 (en) 1998-05-13 1998-07-08 Ml Lab Plc Prevention of surgical adhesions
WO1999058168A1 (en) * 1998-05-13 1999-11-18 Ml Laboratories Plc Dextrin-containing composition for preventing surgical adhesions
US6514534B1 (en) 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US6090997A (en) * 1999-02-10 2000-07-18 University Of Florida Method and composition for preventing surgical adhesions and tissue damage employing fluorinated polymers
WO2003047462A1 (en) * 2001-03-12 2003-06-12 Clemson University Polysaccharide-based polmerizable hydrogels
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7179391B2 (en) * 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
WO2003094937A1 (en) * 2002-05-09 2003-11-20 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
US7845499B2 (en) * 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
WO2004021866A2 (en) * 2002-09-06 2004-03-18 Alleyne Neville D Seal for posterior lateral vertebral disk cavity
US20050177155A1 (en) * 2003-10-28 2005-08-11 Neville Alleyne Anterior adhesion resistant barrier for spine
SE0303588D0 (sv) 2003-12-30 2003-12-30 Bioactive Polymers Ab C O Lund Surface protection of exposed biological tissues
US20080019955A1 (en) 2003-12-30 2008-01-24 Bioactive Polymers Ab Surface Protection of Exposed Biological Tissues
US20060036211A1 (en) * 2004-07-29 2006-02-16 X-Sten, Inc. Spinal ligament modification kit
US7708152B2 (en) * 2005-02-07 2010-05-04 Hanuman Llc Method and apparatus for preparing platelet rich plasma and concentrates thereof
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
EP1848472B1 (de) * 2005-02-07 2015-04-01 Hanuman LLC Vorrichtung und verfahren für ein blutplättchenreiches plasmakonzentrat
US7767656B2 (en) * 2005-04-25 2010-08-03 Molly S Shoichet Blends of temperature sensitive and anionic polymers for drug delivery
US9119901B2 (en) * 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US8696671B2 (en) 2005-07-29 2014-04-15 Vertos Medical Inc. Percutaneous tissue excision devices
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US20070123890A1 (en) * 2005-11-04 2007-05-31 X-Sten, Corp. Tissue retrieval devices and methods
US7942830B2 (en) 2006-05-09 2011-05-17 Vertos Medical, Inc. Ipsilateral approach to minimally invasive ligament decompression procedure
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8430813B2 (en) * 2006-05-26 2013-04-30 Depuy Spine, Inc. Illuminated surgical access system including a surgical access device and integrated light emitter
US20070299459A1 (en) * 2006-06-26 2007-12-27 X-Sten Corp. Percutaneous Tissue Access Device
USD606654S1 (en) 2006-07-31 2009-12-22 Vertos Medical, Inc. Tissue excision device
USD620593S1 (en) 2006-07-31 2010-07-27 Vertos Medical, Inc. Tissue excision device
US20080221383A1 (en) * 2007-02-12 2008-09-11 Vertos Medical, Inc. Tissue excision devices and methods
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2146794B1 (de) 2007-04-12 2016-10-19 Biomet Biologics, LLC Fraktionierungssystem für suspensionen mit trennungsschwimmer
US20100290989A1 (en) * 2007-10-12 2010-11-18 London Health Sciences Centre Research Inc. Compositions affecting hyaluronic acid mediated activity
US20090118709A1 (en) * 2007-11-06 2009-05-07 Vertos Medical, Inc. A Delaware Corporation Tissue Excision Tool, Kits and Methods of Using the Same
EP2620139B1 (de) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1-Rezeptorantagonisten-reiche Lösungen
US8337711B2 (en) * 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8012077B2 (en) * 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
USD598549S1 (en) 2008-09-16 2009-08-18 Vertos Medical, Inc. Surgical trocar
USD621939S1 (en) 2008-10-23 2010-08-17 Vertos Medical, Inc. Tissue modification device
USD611146S1 (en) 2008-10-23 2010-03-02 Vertos Medical, Inc. Tissue modification device
USD619253S1 (en) 2008-10-23 2010-07-06 Vertos Medical, Inc. Tissue modification device
USD619252S1 (en) 2008-10-23 2010-07-06 Vertos Medical, Inc. Tissue modification device
USD610259S1 (en) 2008-10-23 2010-02-16 Vertos Medical, Inc. Tissue modification device
KR101062068B1 (ko) * 2008-12-01 2011-09-02 포항공과대학교 산학협력단 유착방지용 조성물
US20110306565A1 (en) 2009-01-13 2011-12-15 Margit Mahlapuu Hyaluronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) * 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
WO2010125069A1 (en) * 2009-04-28 2010-11-04 Pharmasurgics In Sweden Ab Hyaluronic acid for preventing post surgical adhesions
US9011800B2 (en) * 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
ES2819222T3 (es) * 2009-09-23 2021-04-15 Glenpharma Ab Composiciones y métodos para inducir o mejorar la reparación del tejido conectivo
EP2512516B1 (de) 2009-12-18 2016-02-17 The Governing Council Of The University Of Toronto Injizierbare polymerzusammensetzung zur verwendung als ein zellfreisetzungsträger
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
GB201020300D0 (en) * 2010-11-30 2011-01-12 Vitrolife Sweden Ab Product
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9474767B2 (en) * 2012-11-12 2016-10-25 Warsaw Orthopedic, Inc. Compositions and methods for inhibiting bone growth
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
WO2018049078A1 (en) 2016-09-07 2018-03-15 Vertos Medical, Inc. Percutaneous lateral recess resection methods and instruments
JP2025520556A (ja) 2022-06-16 2025-07-03 ヴェルトス・メディカル，インコーポレイテッド 一体型器具アセンブリ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE456346B (sv) * 1984-07-23 1988-09-26 Pharmacia Ab Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
IN166447B (de) * 1985-11-27 1990-05-12 Ethicon Inc
US4889722A (en) * 1985-12-16 1989-12-26 Ethicon, Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
US4840626A (en) * 1986-09-29 1989-06-20 Johnson & Johnson Patient Care, Inc. Heparin-containing adhesion prevention barrier and process
US4911926A (en) * 1988-11-16 1990-03-27 Mediventures Inc. Method and composition for reducing postsurgical adhesions

Also Published As

Publication number Publication date
WO1990010031A1 (en) 1990-09-07
US5190759A (en) 1993-03-02
SE8900586L (sv) 1990-08-22
EP0418339A1 (de) 1991-03-27
US5358973A (en) 1994-10-25
DK0418339T3 (da) 1995-04-03
DE69013833D1 (de) 1994-12-08
EP0418339B1 (de) 1994-11-02
SE8900586D0 (sv) 1989-02-21
DE69013833T2 (de) 1995-06-08

Similar Documents

Publication Publication Date Title
DE69013833D1 (de) Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.
BR0209688A (pt) Método e composição para reduzir fixação bacteriana em biomateriais
ATE295745T1 (de) Hyaluronsäure-gel, verfahren zur dessen herstellung und hyaluronsäure-gel enthaltendes medizinisches material
DE122005000001I2 (de) Zweiwertige Metallsalze von 2-N, N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxy-thiophens{ure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
GB2197329B (en) Hard tissue substitute composition
GR3034921T3 (en) Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer.
EP0322249A3 (en) Collagen products, processes for the preparation thereof and pharmaceutical compositions containing the same
AU2084092A (en) Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery
ITPD920071A1 (it) Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
ZA908676B (en) Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
RU97102350A (ru) Анти-адгезионный агент
DE3864188D1 (de) Kondom.
ZA895840B (en) N-2,3-butadienyl tri-and tetraaminoalkane derivatives
ATE249225T1 (de) Mannose-6-phosphat enthaltendes mittel und dessen verwendung bei der behandlungfibrotischer erkrankungen
ATE117898T1 (de) Verfahren und mittel zur präventiven behandlung von chirurgischen adhäsionen.
DE69811758D1 (de) Verwendung von Hyaluronsäure zur Herstellung einer wässrigen Lösung verwendbar als intra-artikulare Reinigungslösung
AU2360592A (en) Polyacrylic acid based ophthalmic compositions
DE69900648D1 (de) Dextrinhaltige mischung zur verhinderung von chirurgischen verklebungen
IT1306643B1 (it) Processo per la preparazione dei composti autoreticolati dell'acidoialuronico e dei suoi derivati ottenibili mediante la tecnica
ATE245457T1 (de) Zusammensetzung von fluorinierten polymeren zur vermeidung chirurgischer verklebungen und gewebeschäden
EP0371733A3 (de) Dopamin-beta-hydroxylase-Inhibitoren
PT711163E (pt) Utilizacao de benzidamina no tratamento de estados patologicos provocados por tnf
ATE158719T1 (de) Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung
DE69012818D1 (de) Zusammensetzung zur beseitigung und inaktivierung von schadstoffen im blut oder sonstigen extrazellularen körperflüssigkeiten.
IT8609534A0 (it) Preparato,in particolare collirio o pomata,per il trattamento di alterazioni distrofiche e vascolari dei tessuti oculari.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee